-Reuters BRUSSELS: Nine drugmakers, including Denmark's Lundbeck and India's Ranbaxy, were fined a total of 146 million euros by EU antitrust regulators on Wednesday for blocking the supply of a cheaper anti-depressant medicine to the market. The punishments follow a 2009 report by the European Commission on the pharmaceutical sector, which said "pay-for-delay" deals lead to consumers paying as much as 20 percent more for their medicines. The EU action came two days...

-The Times of India NEW DELHI: BJP leader and cricket administrator Arun Jaitley on Tuesday said the Central Information Commission (CIC) ruling bringing political parties within the ambit of Right to Information (RTI) Act was per se not wrong as long as it applied to their funding. However, he was quick to introduce caveats. "The CIC logic behind applying RTI Act to political parties is that they are given land at concessional...

-The Hindu Aruna Roy's decision to terminate her relationship with the Sonia Gandhi-led National Advisory Council has returned the spotlight to the ideological divide within the ruling establishment on welfare spending. As the civil rights activist noted in her letter to the Congress president, the rupture came over the Manmohan Singh government's refusal to pay statutory minimum wages to workers under the Mahatma Gandhi National Rural Employment Guarantee Act -...

-The Business Standard Angelina Jolie has inadvertently highlighted a key question about patenting Angelina Jolies recent double mastectomy was obviously a very radical decision. It is unusual for a healthy person to opt for pre-emptive surgery to avert the probability, however high it may be, of getting cancer. The tests Jolie relied on are also at the heart of a legal battle, which could affect US biotech patenting norms. Since the US...

-The Economic Times NEW DELHI: You may end up saving more in the months ahead with the Employees Provident Fund Organization (EPFO) readying to re-notify a new definition of "compensation" that will include all your allowances, amid intense lobbying against the move by industry bodies. Currently, employers get away by contributing only 12% of the basic salary and dearness allowance, which is not paid by most companies, towards their share of "matching"...